Product Information
IMATINIB MESYLATE 400 MG TAB is a generic product labeled by Archis Pharma LLC, priced at $2.9484 per EA under NDC 72819018603. Its NADAC has been published 169 times since Apr 5, 2023.
Strength
400 mg/1
Manufacturer
Archis Pharma LLCNDC
72819018603
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA212135On Market Since
9/1/2022
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 400 MG TAB has been published 169 times since Apr 5, 2023, and over the history we have for it it has risen 36.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9484 per EA |
|---|---|
| All-time high | $3.2150 (Mar 11, 2026) |
| All-time low | $1.4080 (Aug 23, 2023) |
| 52-week high | $3.2150 |
| 52-week low | $2.6631 |
| Median price | $2.5597 |
| Average price | $2.4044 |
| Largest weekly change | +33.5% (Sep 20, 2023) |
| Weeks tracked | 169 |
| Tracking since | Apr 5, 2023 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 400 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 400 MG TAB, manufactured by Archis Pharma LLC, is $2.9484 per EA (NDC 72819018603), effective Jun 24, 2026.
How has the price of IMATINIB MESYLATE 400 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 400 MG TAB has risen 36.6%. It has been tracked across 169 weekly CMS publications since Apr 5, 2023.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 400 MG TAB?
Since Apr 5, 2023, the NADAC for IMATINIB MESYLATE 400 MG TAB has ranged from a low of $1.4080 (Aug 23, 2023) to a high of $3.2150 (Mar 11, 2026), with a median of $2.5597 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 400 MG TAB?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, IMATINIB MESYLATE 400 MG TAB, is $2.0356 per EA — about 31% below IMATINIB MESYLATE 400 MG TAB.
Who manufactures IMATINIB MESYLATE 400 MG TAB?
IMATINIB MESYLATE 400 MG TAB (NDC 72819018603) is labeled by Archis Pharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification